￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

medicaldrugs

Is there a domestic version of Cabozantinib?

2026-02-01 22:25:32

Check Details
The specific situation of the targeted drug Pralsetinib entering medical insurance in 2026

2026-02-01 22:25:32

Check Details
Capmatinib/Touradida belongs to which generation of targeted drugs

2026-02-01 22:25:32

Check Details
Aficamten-MYQORZO manual Chinese introduction

2026-02-01 22:25:32

Check Details
The specific efficacy and role of larotrectinib/vitaikai in the treatment of cancer

2026-02-01 22:25:32

Check Details
STOMP trial analysis reveals the immunomodulatory effects of selinezo/silvio in RRMM

2026-02-01 22:25:32

Check Details
Detailed explanation of the efficacy and role of Vigabatrin/vigabatrin in treating epilepsy

2026-02-01 22:25:32

Check Details
How Mobocertinib inhibits EGFR exon 20 to treat disease

2026-02-01 22:25:32

Check Details
Is mirikizumab available in the country? What is the market situation?

2026-02-01 22:25:32

Check Details
What are the combination regimens of selumetinib/coceyu?

2026-02-01 22:25:32

Check Details
Aficamten-MYQORZO’s functions and effects

2026-02-01 22:25:32

Check Details
What are the medical insurance reimbursement conditions for lorlatinib/lorlatinib?

2026-02-01 22:25:32

Check Details
Category
相关知识